How big is the North America Colorectal Cancer Screening Market?

The North America Colorectal Cancer Screening Market size is expected to reach USD 7.15 billion in 2024 and grow at a CAGR of 6.70% to reach USD 9.89 billion by 2029. Read More

What is the current North America Colorectal Cancer Screening Market size?

In 2024, the North America Colorectal Cancer Screening Market size is expected to reach USD 7.15 billion. Read More

Who are the key players in North America Colorectal Cancer Screening Market?

Abbott Laboratories, Epigenomics Inc., Exact Sciences Corporation, Clinical Genomics Technologies Pty Ltd. and Hemosure Inc. are the major companies operating in the North America Colorectal Cancer Screening Market. Read More

What years does this North America Colorectal Cancer Screening Market cover, and what was the market size in 2023?

In 2023, the North America Colorectal Cancer Screening Market size was estimated at USD 6.67 billion. The report covers the North America Colorectal Cancer Screening Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the North America Colorectal Cancer Screening Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

North America Colorectal Cancer Screening Companies

This report lists the top North America Colorectal Cancer Screening companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the North America Colorectal Cancer Screening industry.